Effects of cortisol administration on craving in heroin addicts. 2015

M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
Psychiatric University Clinics Basel, University of Basel, Basel, Switzerland.

Heroin dependence is a severe and chronically relapsing substance use disorder with limited treatment options. Stress is known to increase craving and drug-taking behavior, but it is not known whether the stress hormone cortisol mediates these stress effects or whether cortisol may rather reduce craving, for example, by interfering with addiction memory. The aim of the present study was to determine the effects of cortisol administration on craving in heroin-dependent patients and to determine whether the effects depend on the daily dose of heroin consumption. We used a double-blind, placebo-controlled, cross-over study in 29 heroin-dependent patients in a stable heroin-assisted treatment setting. A single oral dose of 20 mg of cortisol or placebo was administered 105 min before the daily heroin administration. The primary outcome measure was cortisol-induced change in craving. Secondary measures included anxiety, anger and withdrawal symptoms. For the visual analog scale for craving, we found a significant interaction (P = 0.0027) between study medication and heroin-dose group (that is, daily low, medium or high dose of heroin). Cortisol administration reduced craving in patients receiving a low dose of heroin (before heroin administration: P = 0.0019; after heroin administration: P = 0.0074), but not in patients receiving a medium or high dose of heroin. In a picture-rating task with drug-related pictures, cortisol administration did not affect the ratings for the picture-characteristic craving in all the three heroin-dose groups. Cortisol also did not significantly affect secondary outcome measures. In conclusion, a single administration of cortisol leads to reduced craving in low-dose heroin addicts. The present findings might have important clinical implications with regard to understanding stress effects and regarding treatment of addiction.

UI MeSH Term Description Entries
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006556 Heroin Dependence Strong dependence or addiction, both physiological and emotional, upon HEROIN. Heroin Abuse,Heroin Addiction,Heroin Smoking,Abuse, Heroin,Addiction, Heroin,Dependence, Heroin,Heroin Smokings,Smoking, Heroin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000786 Anger A strong emotional feeling of displeasure aroused by being interfered with, injured or threatened. Angers
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover
D064232 Visual Analog Scale A subjective psychometric response scale used to measure distinct behavioral or physiological phenomena based on linear numerical gradient or yes/no alternatives. Analog Scale, Visual,Analog Scales, Visual,Scale, Visual Analog,Scales, Visual Analog,Visual Analog Scales

Related Publications

M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
January 1978, The American journal of drug and alcohol abuse,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
January 2006, Journal of addictive diseases,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
January 1995, Polish journal of pharmacology,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
August 2009, European journal of pharmacology,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
September 1987, Drug and alcohol dependence,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
June 2009, Pharmacology, biochemistry, and behavior,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
October 1993, Revista clinica espanola,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
February 1989, The Indian journal of medical research,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
July 1981, NIDA research monograph,
M Walter, and D Bentz, and N Schicktanz, and A Milnik, and A Aerni, and C Gerhards, and K Schwegler, and M Vogel, and J Blum, and O Schmid, and B Roozendaal, and U E Lang, and S Borgwardt, and D de Quervain
January 2021, Translational psychiatry,
Copied contents to your clipboard!